Search results
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 1 day agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
First Financial Bank Trust Division Has $345,000 Position in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 6 hours agoFirst Financial Bank Trust Division lowered its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.2% during the first quarter, according to the company in its most recent Form 13F filing ...
Rovin Capital UT ADV Acquires 274 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 2 days agoRovin Capital UT ADV lifted its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 20.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange ...
AbbVie (NYSE:ABBV) Stock Price Up 1.5% on Analyst Upgrade
ETF DAILY NEWS· 12 hours agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares rose 1.5% during trading on Tuesday after Piper Sandler raised their price target on the stock from $185.00 to $190.00. Piper Sandler currently ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Michael S. Ryan Inc.
ETF DAILY NEWS· 6 hours agoMichael S. Ryan Inc. lowered its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.6% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor ...
Brevan Howard Capital Management LP Makes New $1.97 Million Investment in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoBrevan Howard Capital Management LP purchased a new position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, Holdings Channel reports. The fund purchased 12,727 shares ...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 16 hours agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 and a 52-week maintenance study, COMMAND2Data showed that clinical remission,
Short Interest in UCB SA (OTCMKTS:UCBJY) Rises By 152.5%
ETF DAILY NEWS· 5 days agoUCB SA (OTCMKTS:UCBJY – Get Free Report) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 15,400 shares, a growth of 152.5% from ...
